Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Alzheimer's Disease

  Free Subscription

Articles published in J Neurosci

Retrieve available abstracts of 75 articles:
HTML format

Single Articles

    February 2024
  1. REN Q, Wang S, Li J, Cao K, et al
    Novel social stimulation ameliorates memory deficit in Alzheimer's disease model through activating alpha-secretase.
    J Neurosci. 2024 Feb 28:e1689232024. doi: 10.1523/JNEUROSCI.1689-23.2024.
    PubMed     Abstract available

  2. ZHOU J, Wearn A, Huck J, Hughes C, et al
    Iron deposition and distribution across the hippocampus is associated with pattern separation and pattern completion in older adults at risk for Alzheimer's disease.
    J Neurosci. 2024 Feb 22:e1973232024. doi: 10.1523/JNEUROSCI.1973-23.2024.
    PubMed     Abstract available

  3. MABOUDIAN SA, Willbrand EH, Jagust WJ, Weiner KS, et al
    Defining overlooked structures reveals new associations between cortex and cognition in aging and Alzheimer's disease.
    J Neurosci. 2024 Feb 21:e1714232024. doi: 10.1523/JNEUROSCI.1714-23.2024.
    PubMed     Abstract available

  4. KIM CM, Diez I, Bueicheku E, Ahn S, et al
    Spatiotemporal Correlation between Amyloid and Tau Accumulations Underlies Cognitive Changes in Aging.
    J Neurosci. 2024;44:e0488232023.
    PubMed     Abstract available

  5. PHILLIPS JS, Robinson JL, Cousins KAQ, Wolk DA, et al
    Polypathologic Associations with Gray Matter Atrophy in Neurodegenerative Disease.
    J Neurosci. 2024;44:e0808232023.
    PubMed     Abstract available

    January 2024
  6. NIRAULA S, Yan SS, Subramanian J
    Amyloid Pathology Impairs Experience-Dependent Inhibitory Synaptic Plasticity.
    J Neurosci. 2024;44:e0702232023.
    PubMed     Abstract available

  7. LOWERISON MR, Sekaran NVC, Dong Z, Chen X, et al
    Super-resolution ultrasound reveals cerebrovascular impairment in a mouse model of Alzheimer's Disease.
    J Neurosci. 2024 Jan 22:e1251232024. doi: 10.1523/JNEUROSCI.1251-23.2024.
    PubMed     Abstract available

    November 2023
  8. LUKE R, Alymova I
    Unraveling the Mechanisms Underlying Disordered Sleep in Alzheimer's Disease.
    J Neurosci. 2023;43:7899-7901.

  9. BARTOSCH AMW, Youth EHH, Hansen S, Wu Y, et al
    ZCCHC17 modulates neuronal RNA splicing and supports cognitive resilience in Alzheimer's disease.
    J Neurosci. 2023 Nov 22:JN-RM-2324-22. doi: 10.1523/JNEUROSCI.2324-22.2023.
    PubMed     Abstract available

  10. IWATSUBO T, Irizarry MC, Lewcock JW, Carrillo MC, et al
    Alzheimer's targeted treatments: focus on amyloid and inflammation.
    J Neurosci. 2023 Nov 14:JN-DP-1576-23. doi: 10.1523/JNEUROSCI.1576-23.2023.
    PubMed     Abstract available

    October 2023
  11. ECKMAN EA, Clausen DM, Sole-Domenech S, Lee CW, et al
    Nascent Abeta42 fibrillization in synaptic endosomes precedes plaque formation in a mouse model of Alzheimer's like beta-amyloidosis.
    J Neurosci. 2023 Oct 26:JN-RM-1318-23. doi: 10.1523/JNEUROSCI.1318-23.2023.
    PubMed     Abstract available

  12. SANO T, Ochiai T, Nagayama T, Nakamura A, et al
    Genetic Reduction of Insulin Signaling Mitigates Amyloid-beta Deposition by Promoting Expression of Extracellular Matrix Proteins in the Brain.
    J Neurosci. 2023;43:7226-7241.
    PubMed     Abstract available

  13. ALLARD S, Hussain Shuler MG
    Cholinergic Reinforcement Signaling Is Impaired by Amyloidosis Prior to Its Synaptic Loss.
    J Neurosci. 2023;43:6988-7005.
    PubMed     Abstract available

  14. BHEMBRE N, Bonthron C, Opazo P
    Synaptic Compensatory Plasticity in Alzheimer's Disease.
    J Neurosci. 2023;43:6833-6840.
    PubMed     Abstract available

    September 2023
  15. ZHANG Z, Chan MY, Han L, Carreno CA, et al
    Dissociable effects of Alzheimer's Disease-related cognitive dysfunction and aging on functional brain network segregation.
    J Neurosci. 2023 Sep 15:JN-RM-0579-23. doi: 10.1523/JNEUROSCI.0579-23.2023.
    PubMed     Abstract available

  16. CHEN L, Christenson Wick Z, Vetere LM, Vaughan N, et al
    Progressive excitability changes in the medial entorhinal cortex in the 3xTg mouse model of Alzheimer's disease pathology.
    J Neurosci. 2023 Sep 15:JN-RM-1204-23. doi: 10.1523/JNEUROSCI.1204-23.2023.
    PubMed     Abstract available

  17. YIN P, Cai Y, Cui T, Berg AJ, et al
    Glial Sphingosine-mediated Epigenetic Regulation Stabilizes Synaptic Function in Drosophila Models of Alzheimer's Disease.
    J Neurosci. 2023 Sep 5:JN-RM-0515-23. doi: 10.1523/JNEUROSCI.0515-23.2023.
    PubMed     Abstract available

    August 2023
  18. CASSADY KE, Chen X, Adams JN, Harrison TM, et al
    Effect of Alzheimer's pathology on task-related brain network reconfiguration in aging.
    J Neurosci. 2023 Aug 18:JN-RM-0023-23. doi: 10.1523/JNEUROSCI.0023-23.2023.
    PubMed     Abstract available

  19. ZHOU Y, Xie L, der JS, Schuster IS, et al
    Dietary fiber and microbiota metabolite receptors enhance cognition and alleviate disease in the 5xFAD mouse model of Alzheimer's disease.
    J Neurosci. 2023 Aug 17:JN-RM-0724-23. doi: 10.1523/JNEUROSCI.0724-23.2023.
    PubMed     Abstract available

  20. ONDREJCAK T, Klyubin I, Hu NW, O'Malley TT, et al
    Tau and Amyloid beta Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation in Vivo.
    J Neurosci. 2023;43:5870-5879.
    PubMed     Abstract available

  21. YAO AY, Halloran PJ, Ge Y, Singh N, et al
    Bace1 deletion in the adult reverses epileptiform activity and sleep-wake disturbances in AD mice.
    J Neurosci. 2023 Aug 3:JN-RM-2124-22. doi: 10.1523/JNEUROSCI.2124-22.2023.
    PubMed     Abstract available

    July 2023
  22. LENZ M, Eichler A, Kruse P, Galanis C, et al
    The Amyloid Precursor Protein Regulates Synaptic Transmission at Medial Perforant Path Synapses.
    J Neurosci. 2023;43:5290-5304.
    PubMed     Abstract available

    June 2023
  23. KELLY P, Sanchez-Mico MV, Hou SS, Whiteman S, et al
    Neuronally Derived Soluble Abeta Evokes Cell-Wide Astrocytic Calcium Dysregulation in Absence of Amyloid Plaques in Vivo.
    J Neurosci. 2023;43:4926-4940.
    PubMed     Abstract available

  24. MEDINA-SAMAME A, Paller E, Bril MR, Archvadze A, et al
    Role of Neurexins in Alzheimer's Disease.
    J Neurosci. 2023;43:4194-4196.

    May 2023
  25. LANDRY O, Francois A, Oye Mintsa Mi-Mba MF, Traversy MT, et al
    Postsynaptic protein Shank3a deficiency synergizes with Alzheimer's disease neuropathology to impair cognitive performance in the 3xTg-AD murine model.
    J Neurosci. 2023 May 30:JN-RM-1945-22. doi: 10.1523/JNEUROSCI.1945-22.2023.
    PubMed     Abstract available

  26. BRYANT A, Li Z, Jayakumar R, Serrano-Pozo A, et al
    Endothelial Cells are Heterogeneous in Different Brain Regions and are Dramatically Altered in Alzheimer's Disease.
    J Neurosci. 2023 May 17:JN-RM-0237-23. doi: 10.1523/JNEUROSCI.0237-23.2023.
    PubMed     Abstract available

  27. WALKER CK, Greathouse KM, Tuscher JJ, Dammer EB, et al
    Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length.
    J Neurosci. 2023;43:3764-3785.
    PubMed     Abstract available

    April 2023
  28. ZHANG K, Chen L, Li Y, Paez AG, et al
    Differential Laminar Activation Dissociates Encoding and Retrieval in the Human Medial and Lateral Entorhinal Cortex.
    J Neurosci. 2023;43:2874-2884.
    PubMed     Abstract available

    March 2023
  29. SOMPOL P, Gollihue JL, Weiss BE, Lin RL, et al
    Targeting Astrocyte Signaling Alleviates Cerebrovascular and Synaptic Function Deficits in a Diet-Based Mouse Model of Small Cerebral Vessel Disease.
    J Neurosci. 2023;43:1797-1813.
    PubMed     Abstract available

  30. MA F, Akolkar H, Xu J, Liu Y, et al
    The Amyloid Precursor Protein Modulates the Position and Length of the Axon Initial Segment.
    J Neurosci. 2023;43:1830-1844.
    PubMed     Abstract available

    February 2023
  31. BHATNAGAR A, Krick K, Karisetty BC, Armour EM, et al
    Tip60's novel RNA-binding function modulates alternative splicing of pre-mRNA targets implicated in Alzheimer's Disease.
    J Neurosci. 2023 Feb 24:JN-RM-2331-22. doi: 10.1523/JNEUROSCI.2331-22.2023.
    PubMed     Abstract available

    January 2023
  32. CRUZAT J, Herzog R, Prado P, Sanz-Perl Y, et al
    J Neurosci. 2023 Jan 27:JN-RM-1312-22. doi: 10.1523/JNEUROSCI.1312-22.2022.
    PubMed     Abstract available

  33. ZHANG H, Knight C, Chen SRW, Bezprozvanny I, et al
    A gating mutation in ryanodine receptor type 2 rescues phenotypes of Alzheimer's disease mouse models by upregulating neuronal autophagy.
    J Neurosci. 2023 Jan 9:JN-RM-1820-22. doi: 10.1523/JNEUROSCI.1820-22.2022.
    PubMed     Abstract available

    November 2022
  34. CVETKOVSKA V, Ge Y, Xu Q, Li S, et al
    Neurexin-beta Mediates the Synaptogenic Activity of Amyloid Precursor Protein.
    J Neurosci. 2022;42:8936-8947.
    PubMed     Abstract available

  35. ADAMS JN, Kim S, Rizvi B, Sathishkumar M, et al
    Entorhinal-Hippocampal Circuit Integrity Is Related to Mnemonic Discrimination and Amyloid-beta Pathology in Older Adults.
    J Neurosci. 2022;42:8742-8753.
    PubMed     Abstract available

  36. NASSIF C, Kawles A, Ayala I, Minogue G, et al
    Integrity of Neuronal Size in the Entorhinal Cortex Is a Biological Substrate of Exceptional Cognitive Aging.
    J Neurosci. 2022;42:8587-8594.
    PubMed     Abstract available

    October 2022
  37. BARTHET G, de-Sa AM, Zhang P, Deforges S, et al
    Presenilin and APP regulate synaptic kainate receptors.
    J Neurosci. 2022;42:9253-62.
    PubMed     Abstract available

    August 2022
  38. MUMFORD P, Tosh J, Anderle S, Gkanatsiou Wikberg E, et al
    Genetic Mapping of APP and Amyloid-beta Biology Modulation by Trisomy 21.
    J Neurosci. 2022;42:6453-6468.
    PubMed     Abstract available

  39. GUO T, Pan X, Jiang G, Zhang D, et al
    Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer's mouse models.
    J Neurosci. 2022 Aug 9. pii: JNEUROSCI.1060-22.2022.
    PubMed     Abstract available

  40. WALSH C, Ridler T, Margetts-Smith G, Garcia Garrido M, et al
    Beta bursting in the retrosplenial cortex is a neurophysiological correlate of environmental novelty which is disrupted in a mouse model of Alzheimer's disease.
    J Neurosci. 2022 Aug 4. pii: JNEUROSCI.0890-21.2022.
    PubMed     Abstract available

  41. BAIER MP, Nagaraja RY, Yarbrough HP, Owen DB, et al
    Selective Ablation of Sod2 in Astrocytes Induces Sex-Specific Effects on Cognitive Function, d-Serine Availability, and Astrogliosis.
    J Neurosci. 2022;42:5992-6006.
    PubMed     Abstract available

  42. CAI C, Wang L, Li S, Lou S, et al
    Ras Inhibitor Lonafarnib Rescues Structural and Functional Impairments of Synapses of Abeta1-42 Mice via alpha7nAChR-Dependent BDNF Upregulation.
    J Neurosci. 2022;42:6090-6107.
    PubMed     Abstract available

    July 2022
  43. WANG S, Fu Y, Miyata T, Matsumoto S, et al
    Functional cooperation of alpha-synuclein and tau is essential for proper corticogenesis.
    J Neurosci. 2022 Jul 29. pii: JNEUROSCI.0396-22.2022.
    PubMed     Abstract available

  44. BOLD CS, Baltissen D, Ludewig S, Back MK, et al
    APPsalpha Rescues Tau-Induced Synaptic Pathology.
    J Neurosci. 2022;42:5782-5802.
    PubMed     Abstract available

    June 2022
  45. WANG LH, Lin CY, Lin YM, Buee L, et al
    Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration.
    J Neurosci. 2022;42:5102-5114.
    PubMed     Abstract available

  46. SHI Q, Chang C, Saliba A, Bhat MA, et al
    Microglial mTOR Activation Upregulates Trem2 and Enhances beta-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model.
    J Neurosci. 2022 Jun 2. pii: JNEUROSCI.2427-21.2022.
    PubMed     Abstract available

    May 2022

  47. Erratum: Larson et al., "Soluble alpha-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology".
    J Neurosci. 2022 May 26. pii: JNEUROSCI.0896-22.2022.

  48. TU G, Halawa A, Yu X, Gillman S, et al
    Outcome-Locked Cholinergic Signaling Suppresses Prefrontal Encoding of Stimulus Associations.
    J Neurosci. 2022;42:4202-4214.
    PubMed     Abstract available

    April 2022
  49. DE OLIVEIRA P, Cella C, Locker N, Ravindran KKG, et al
    Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice.
    J Neurosci. 2022;42:3494-3509.
    PubMed     Abstract available

    January 2022

  50. Erratum: Takamura et al., "Modality-Specific Impairment of Hippocampal CA1 Neurons of Alzheimer's Disease Model Mice".
    J Neurosci. 2022 Jan 27. pii: JNEUROSCI.2522-21.2021.

  51. DE FLORES R, Das SR, Xie L, Wisse LEM, et al
    Medial temporal lobe networks in Alzheimer's disease: structural and molecular vulnerabilities.
    J Neurosci. 2022 Jan 26. pii: JNEUROSCI.0949-21.2021.
    PubMed     Abstract available

  52. KOCAGONCU E, Nesbitt D, Emery T, Hughes L, et al
    Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease.
    J Neurosci. 2022 Jan 10. pii: JNEUROSCI.0697-21.2021.
    PubMed     Abstract available

  53. ISLAM S, Sun Y, Gao Y, Nakamura T, et al
    Presenilin is essential for ApoE secretion, a novel role of presenilin involved in Alzheimer's disease pathogenesis.
    J Neurosci. 2022 Jan 5. pii: JNEUROSCI.2039-21.2021.
    PubMed     Abstract available

    December 2021

  54. Expression of Concern: Wang et al., "Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A".
    J Neurosci. 2021 Dec 17. pii: JNEUROSCI.2306-21.2021.

  55. Expression of Concern: Wang et al., "Dissociating beta-Amyloid from alpha7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes alpha7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain".
    J Neurosci. 2021 Dec 17. pii: JNEUROSCI.2307-21.2021.

  56. CUI J, Ait-Ghezala G, Sambamurti K, Gao F, et al
    Sex-specific regulation of beta-Secretase: a novel estrogen response element (ERE)-dependent mechanism in Alzheimer's disease.
    J Neurosci. 2021 Dec 9. pii: JNEUROSCI.0864-20.2021.
    PubMed     Abstract available

  57. CHAVES RS, Tran M, Holder AR, Balcer AM, et al
    Amyloidogenic Processing of Amyloid Precursor Protein Drives Stretch-Induced Disruption of Axonal Transport in hiPSC-Derived Neurons.
    J Neurosci. 2021;41:10034-10053.
    PubMed     Abstract available

    November 2021

  58. Erratum: Medeiros et al., "Connecting TNF-alpha Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid beta Protein".
    J Neurosci. 2021 Nov 17. pii: JNEUROSCI.2000-21.2021.

  59. Erratum: Wang et al., "Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A".
    J Neurosci. 2021 Nov 10. pii: JNEUROSCI.2154-21.2021.

    August 2021
  60. WU M, Liu CZ, Barrall EA, Rissman RA, et al
    Unbalanced regulation of alpha7 nAChRs by Ly6h and NACHO contributes to neurotoxicity in Alzheimer's disease.
    J Neurosci. 2021 Aug 26. pii: JNEUROSCI.0494-21.2021.
    PubMed     Abstract available

    May 2021
  61. OAKLEY DH, Klickstein N, Commins C, Chung M, et al
    Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    J Neurosci. 2021;41:4335-4348.
    PubMed     Abstract available

  62. SALAMONE PC, Legaz A, Sedeno L, Moguilner S, et al
    Interoception Primes Emotional Processing: Multimodal Evidence from Neurodegeneration.
    J Neurosci. 2021;41:4276-4292.
    PubMed     Abstract available

  63. TAKAMURA R, Mizuta K, Sekine Y, Islam T, et al
    Modality specific impairment of hippocampal CA1 neurons of Alzheimer's disease model mice.
    J Neurosci. 2021 May 10. pii: JNEUROSCI.0208-21.2021.
    PubMed     Abstract available

  64. GOODMAN AM, Langner BM, Jackson N, Alex C, et al
    Heightened hippocampal beta-adrenergic receptor function drives synaptic potentiation and supports learning and memory in the TgF344-AD rat model during prodromal Alzheimer's disease.
    J Neurosci. 2021 May 5. pii: JNEUROSCI.0119-21.2021.
    PubMed     Abstract available

    April 2021
  65. ADAMS JN, Maass A, Berron D, Harrison TM, et al
    Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe.
    J Neurosci. 2021;41:3917-3931.
    PubMed     Abstract available

  66. VAN SKIKE CE, Hussong SA, Hernandez SF, Banh AQ, et al
    mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer's disease.
    J Neurosci. 2021 Apr 20. pii: JNEUROSCI.2144-20.2021.
    PubMed     Abstract available

    March 2021
  67. MORENO-JIMENEZ EP, Terreros-Roncal J, Flor-Garcia M, Rabano A, et al
    Evidences for Adult Hippocampal Neurogenesis in Humans.
    J Neurosci. 2021;41:2541-2553.
    PubMed     Abstract available

    February 2021
  68. SANCHEZ-AGUILERA A, Quintanilla JP
    Sharp Wave Ripples in Alzheimer's Disease: In Search of Mechanisms.
    J Neurosci. 2021;41:1366-1370.

  69. RIVERS-AUTY J, Tapia VS, White CS, Daniels MJ, et al
    Zinc status alters Alzheimer's disease progression through NLRP3-dependent inflammation.
    J Neurosci. 2021 Feb 16. pii: JNEUROSCI.1980-20.2020.
    PubMed     Abstract available

    November 2020
  70. FRACASSI A, Marcatti M, Zolochevska O, Tabor N, et al
    Oxidative damage and antioxidant response in frontal cortex of demented and non-demented individuals with Alzheimer's neuropathology.
    J Neurosci. 2020 Nov 24. pii: JNEUROSCI.0295-20.2020.
    PubMed     Abstract available

    October 2020
  71. ALBRECHT D, Isenberg AL, Stradford J, Monreal T, et al
    Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.
    J Neurosci. 2020;40:8573-8586.
    PubMed     Abstract available

  72. Erratum: Forny-Germano et al., "Alzheimer's Disease-Like Pathology Induced by Amyloid-beta Oligomers in Nonhuman Primates".
    J Neurosci. 2020 Oct 6. pii: JNEUROSCI.1827-20.2020.

    September 2020
  73. CHEN W, Wang M, Zhu M, Xiong W, et al
    14,15-epoxyeicosatrienoic acid alleviates pathology in a mouse model of Alzheimer's disease.
    J Neurosci. 2020 Sep 24. pii: JNEUROSCI.1246-20.2020.
    PubMed     Abstract available

  74. ZHANG H, Lin A, Gong P, Chen Y, et al
    The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.
    J Neurosci. 2020;40:6991-7007.
    PubMed     Abstract available

    July 2020
  75. ZHANG H, Chen W, Tan Z, Zhang L, et al
    A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Abeta Clearance.
    J Neurosci. 2020;40:5347-5361.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.